Mindray's BeneVision N-Series is the first patient monitoring platform to integrate Edwards' FloTrac™ sensor technology to offer greater insights into advanced hemodynamic monitoring to manage ...

IRVINE, CA--(Marketwire - Oct 10, 2012) - Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, announced today that it has ...

Detailed price information for Edwards Lifesciences Corp (EW-N) from The Globe and Mail including charting and trades.

IRVINE, Calif. and BRANFORD, Conn., Feb. 12, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and ...

Big data is the big buzzword in healthcare, and Edwards Lifesciences Corp. (NYSE: EW) is no exception—it’s made it part of a strategy to continue growing one of its three main business lines: critical ...

Edwards Lifesciences Corporation (NYSE:EW) ranks among the best medical device stocks to invest in. Piper Sandler maintained its Overweight rating and $90 price target for Edwards Lifesciences ...

Hemodynamic monitoring is a cornerstone of contemporary critical care and perioperative management, providing essential insights into cardiovascular function. Central to this approach is the ...

Please provide your email address to receive an email when new articles are posted on . A noninvasive monitoring system identified short-term hemodynamic changes early after transcatheter aortic valve ...

Combination unlocks new future value-creation opportunities and is expected to be immediately accretive to BD revenue growth, adjusted gross margin, adjusted operating margin and adjusted EPS Expands ...

In a meta-analysis of three trials, remote hemodynamic monitoring was associated with reduced risk for death and HF hospitalization in patients with HF with reduced ejection fraction, researchers ...

Shares of medical technology company Becton, Dickinson And Company (NYSE:BDX) are trading higher after the company said it will acquire Edwards Lifesciences Corp’s (NYSE:EW) Critical Care product ...